While the Mcl-1 protein levels were increased in the presence of CPI-613, we detected a reduction in Bcl-xL protein levels in different GBM cells (GBM22, KNS42, GBM43, NCH644, and GBM12) (Figure 2A). The gene discussed is BCL2L1; the disease is glioblastoma.